Clinical Trial

Peanuts for Cardiometabolic, Brain, and Intestinal Health

Recruiting
View on ClinicalTrials.gov →
Summary
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-04; most recent amendment 2026-03-23.
Trial Details
NCT Number NCT06867198
Lead Sponsor Georgia State University
Collaborators: United States Department of Agriculture (USDA), The Peanut Institute
Conditions Prediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Cognition, Microvascular Function, Gut Microbiota, Endothelial Function (Reactive Hyperemia), Arterial Stiffness, Blood Pressure, Adult
Enrollment 72 participants
Start Date 2025-03-06
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-27